Kala Pharmaceuticals Inc.
13F holders, Q2 2026 (June 30)1holders −2
0new positions
2sold out
$1.67avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Kala Pharmaceuticals Inc. in their 13F filings, down 2 from Q1 2026. 0 opened new positions and 2 sold out. The largest holder was Harbour Investments, Inc. ($5).
- Company
- Kala Pharmaceuticals Inc.
- Filed as
- KALA BIO INC COM (Q2 2026)
- CUSIP
- 483119103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $26 |
All 13F filers, Q1 2026 → Q2 2026: 301 shares sold, net −301 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Harbour Investments, Inc. | 0.00% | Reduce -98.0% | 3 | $5 |
"% of holder's portfolio" is KALA PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Kala Pharmaceuticals Inc. the manager owns.